MENU
NOAR – COST Action CA19114

Network for Optimized Astatine labeled Radiopharmaceuticals

Know More

Latest News

News

Framatome and IBA to partner to develop an Astatine-211 CyclotronNetwork in Europe and the USA

25 – Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announced they have signed a Memorandum Of Understanding to start a strategic partnership...
Read More
News

COST NOAR Third Global Meeting - Minutes

3th GLOBAL MEETING WG & Core Group meeting of the COST Action CA19114 Network for Optimized Astatine Labeled Radiopharmaceuticals minutes:
Read More
ITC Conference Grants

Inclusiveness Target Country (ITC) Conference Grant – 4th call

Inclusiveness Target Countries (ITC) Conference Grants consist in grants awarded to Young Researchers and Innovators affiliated in an Inclusiveness Target Country (ITC) / Near Neighbour Country (NNC) to present their own work at an international well-recognized conferences. Presentations must be related to topics of the NOAR COST Action CA19114 and conferences should not be organized...
Read More
News

Short Term Scientific Mission (STSM) – 4th call

Short Term Scientific Mission (STSM) is an exchange visit to support individual mobility, strengthen existing networks and foster collaboration between COST Action Participants. The STSM should specifically contribute to the scientific objectives of the COST Action, helping to achieve the Action MoU objectives and deliverables, whilst simultaneously allowing those partaking in the missions to learn...
Read More
News

NOMRad - NOMATEN International Radiopharmaceutical Conference

The registration form is available on the conference here. Dear Colleagues,  Friends, NOMATEN Centre of Excellence located at the National Centre for Nuclear Research (NCBJ) invites you to save the date and make plans to join us for the International Radiopharmaceutical Conference NOMRad which will be held June 25 – 27, 2024 at the Novotel...
Read More
News

3rd Global Meeting

3rd Global Meeting of the COST Action CA19114 Nantes, France 1-3rd of October 2024 Save the date!
Read More

Events

Events

COST NOAR Third Global Meeting - From 1 to 3 October 2024 in Nantes

This international Meeting, fully dedicated to astatine-211, aims to convene actors from around the world while emphasizing sustainable practices. These three days will offer a comprehensive overview of the accomplishments made over the past four years within this European network comprising academic and industrial stakeholders. Bringing together 150 participants from Europe, America, and Asia representing...
Read More
Events

International Radiopharmaceutical Conference NOMRad

NOMATEN Centre of Excellence, organizes the International Radiopharmaceutical Conference NOMRad which will be held 25-27 June 2024 in Warsaw, Poland. The conference will focus on topics related to radiopharmaceuticals development, including production of medical radioisotopes, new labelling methods and preclinical and clinical radiopharmaceuticals’ evaluation. There will be also presented talks on astatine production and studies...
Read More
Events

ISI NucMed 2023

Registration for ISI NucMed thematic school 2023 in Nantes is open!July 3-6, 2023 – Nantes (France) Over four days, 20 participants will deepen their knowledge in some of the main fields of nuclear medicine research, with a focus on alpha-emitting radionuclides (astatine-211 especially). They have the opportunity to meet some of the best international experts...
Read More
Events

2nd Global NOAR meeting

Deadline for registration EXTENDED to April 7th. The second Global meeting of the NOAR project will be organized in Coimbra, Portugal, from 9-11th May 2023! The agenda (to be published soon) will include invited speakers & round table discussions both from academia and industry, all focused on targeted alpha therapy with astatine-211. For specific questions...
Read More

About the Action

NOAR COST Action brings together European and international excellence labs, astatine-211 production centers, hospitals, industry and patient associations from more than 20 countries, thus covering the whole value chain of innovation: production, chemistry, radiochemistry, biology, preclinical and clinical research and delivery of radiopharmaceuticals to patients. A European web portal will be created containing information for patients, practitioners, researchers, Industry and as a contact point for National and European patient associations.

Know more

Are you interested in joining us?

We are an open, interdisciplinary and growing network welcoming new members to contribute to our activities.

Join Us Now

Are you interested in joining us?​

We are an open, interdisciplinary and growing network welcoming new members to contribute to our activities.

© 2021 NOAR – COST ACTION CA19114
Privacy Policy

COST Association
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
Action Details

Grant Holder: GIP ARRONAX – France
Action Chair: Dr Jean-Francois GESTIN
Action Vice Chair: Dr Emma ANEHEIM
Science Officer: Dr Inga DADESHIDZE
Action duration: 22 October 2020 to 21 October 2024

Design by Boutik